VIVACTIL

Post-LOE

protriptyline hydrochloride

Molecular Devices

ANDAORALTABLET

Approved

Aug 1995

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

VIVACTIL (protriptyline hydrochloride) by Molecular Devices is clinical pharmacology protriptyline hydrochloride is an antidepressant agent. Approved for symptoms of mental depression in patients. First approved in 1995.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Protriptyline hydrochloride is an antidepressant agent. The mechanism of its antidepressant action in man is not known. It is not a monoamine oxidase inhibitor, and it does not act primarily by stimulation of the central nervous system. Protriptyline has been found in some…

Indications (1)

symptoms of mental depression in patients

Company

Worked on VIVACTIL at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.